NRX Pharmaceuticals: schedules 2026 annual meeting for Dec 17, 2026

What happened

• The board of directors of NRX Pharmaceuticals, Inc. established Dec 17, 2026 as the date of the 2026 annual meeting of stockholders and set Oct 28, 2026 as the record date for determining stockholders entitled to vote.
• The 2026 annual meeting will be held at 10:00 a.m., Eastern Time, in a virtual-only format conducted by live webcast. The company said additional details, including matters to be voted on and instructions for accessing the virtual meeting, will be set forth in its definitive proxy statement to be filed with the SEC.
• Because the meeting date is more than 30 days before the one-year anniversary of the company’s 2025 annual meeting (Mar 23, 2026), previously disclosed deadlines for stockholder proposals and director nominations no longer apply and the company provided revised deadlines.

Key details

• Meeting date: Dec 17, 2026; meeting time: 10:00 a.m., Eastern Time; format: virtual-only by live webcast.
• Record date for voting: Oct 28, 2026.
• Rule 14a-8 proposals for inclusion in proxy materials must be received by close of business on Oct 25, 2026 at the company’s principal executive offices.
• Advance notice proposals and director nominations under the bylaws must be received by close of business on Oct 25, 2026; notice required under Rule 14a-19 (universal proxy) must be provided no later than Oct 26, 2026.

Why it may matter

• Item reported: Item 8.01 (Other events). The filing covers the scheduling of the 2026 annual meeting and the related deadlines for submitting stockholder proposals, director nominations and universal proxy notices.
  A filing does not show why the insider traded or why the company acted.